• 1
    TEDES. An epidemiological study of erectile dysfunction in Thailand (part 1: prevalence). Thai Erectile Dysfunction Epidemiologic Study Group (TEDES). J Med Assoc Thai. 2000;83:872879.
  • 2
    Braun M, Wassmer G, Klotz T. Epidemiology of erectile dysfunction: results of the “Cologne Male Survey”. Int J Impot Res. 2000;12:305311.
  • 3
    Martin-Morales A, Sanchez-Cruz JJ, Saenz TI. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol. 2001;166:569574.
  • 4
    NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA. 1993;270:8390.
  • 5
    Kaiser FE, Viosca SP, Morley JE, et al. Impotence and aging: clinical and hormonal factors. J Am Geriatr Soc. 1988;36:511519.
  • 6
    Seftel AD, Sun P, Swindle R. The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol. 2004;171:23412345.
  • 7
    Shabsigh R, Fishman IJ, Schum C, et al. Cigarette smoking and other vascular risk factors in vasculogenic impotence. Urology. 1991;38:227232.
  • 8
    Derby CA, Mohr BA, Goldstein I, et al. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology. 2000;56:302306.
  • 9
    Solomon H, et al. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart. 2003;89:251253.
  • 10
    Montorsi F, et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol. 2003;44:360365.
  • 11
    Kloner R. Erectile dysfunction in the cardiac patient: how common and how should we treat? J Urol. 2003;170:S46S50.
  • 12
    Feldman HA, Goldstein I, Hatzichristou DG. Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol. 1994;151:5461.
  • 13
    Rosen RC, Kostis JB. Overview of phosphodiesterase 5 inhibition in erectile dysfunction. Am J Cardiol. 2003;92:9M18M.
  • 14
    Stewart KJ, Bacher AC, Turner KL, et al. Effects of exercise on blood pressure in older person. Arch Intern Med. 2005;165:756762.
  • 15
    Ishikawa-Takata K, Ohta T, Tanaka H. How much exercise is required to reduce blood pressure in essential hypertension. A dose response study. Am J Hypertens. 2003;16:629633.
  • 16
    Engstrom G, Hedblad B, Janzon L. Hypertensive men who exercise regularly have lower rate of cardiovascular mortality. J Hypertens. 1999;17:737742.
  • 17
    American College of Sport Medicine. Physical activity, physical Fitness and hypertension. Med Sci Sports Exerc. 1993;25:ix.
  • 18
    Townsend RR, Mcfadden TC, Ford V, et al. A randomized double blind, placebo-controlled trial of casein protein hydrolysnte (C12 peptide) in human essential hypertension. Am J Hypertens. 2004;17:10561058.
  • 19
    Bachorik PS. Collection of blood sample for lipoprotein analysis. Clin Chem. 1982;28:13751378.
  • 20
    Barbieri M, Ferrucci L, Corsi AM, et al. Is chronic inflammation a determinant of blood pressure in the elderly? AJH. 2003;16:537543.
  • 21
    American College of Sports Medicine. ASCM’s Guidelines for Exercise Testing and Prescription 5th ed. Baltimore, MD: Williams & Wilkins; 1995.
  • 22
    Golding LA, Meyers CR, Sinniny WE. Way to Physical Fitness. The Complete Carnote to Fitness Testing and Instruction, 3rd ed. Champaign IL: Human Kinetics Publishers; 1989.
  • 23
    Mancia G, Parati G, Pomidossi G, et al. Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension. 1987;9:209215.
  • 24
    Salako LA. Treatment of Hypertension: Cardiovascular Disease in Africa. Ibadan: Ciba Geigy Ltd.; 1976.
  • 25
    Katzung BG. Basic and Clinical Pharmacology, 7th ed. New York: Lange Medical Books/McGraw (Craw) Hill; 1998.
  • 26
    Kullo DI, Khaleghi M, Hensrud DD. Markers of inflammation Are inversely associated with VO2max in symptomatic men. J Appl Physiol. 2007;102:13741379.
  • 27
    Hjestuen A, Anderssen SA, Holme I, et al. Makers of inflammatory are inversely related to physical activity and fitness in sedentary men with treated hypertension. Am J Hypertens. 2006;19:669675.
  • 28
    Wannamethee SG, Lowe GD, Whincup PH, et al. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation. 2002;105:17851790.
  • 29
    Abramson JL, Vaccarino V. Relationship between physical activity and ninflammation among apparently healthy middle-aged and older US adults. Arch Intern Med. 2002;162:12861292.
  • 30
    King DE, Carek P, Mainous AG III, et al. Inflammatory markers and exercise: differences related to exercise type. Med Sci Sports Exerc. 2003;35:575581.
  • 31
    Geffken D, Cushman M, Burke G, et al. Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol. 2001;153:242250.
  • 32
    Pischon T, Hankinson SE, Hotamisligil GS, et al. Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers. Obes Res. 2003;11:10551064.
  • 33
    Colbert LH, Visser M, Simonsick EM, et al. Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2004;52:10981104.
  • 34
    MacDonald JR, Hogben CD, Tarnopolski MA, et al. Post exercise hypertension is sustained during subsequent bouts of mild exercise and simulated activities of daily living. J Hum Hypertens. 2001;15:567571.
  • 35
    Halliwill JR. Mechanisms and clinical implications of post exercise hypertension in human exercise and sports. Sci Rev. 2001;29:65.
  • 36
    Albert MA, Glynn RJ, Ridker PM. Effect of physical activity on serum C-reactive protein. Am J Cardiol. 2004;93:221225.